APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Diagnostics

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

Selected research

Industry Growth & Trends

Global Influenza Diagnostics Industry Growth and Trends Forecast to 2032

22 December 2025104 pages

Choose your research edition.

Industry ResearchInfluenza Diagnostics Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Diagnostics Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Influenza Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Diagnostics Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Diagnostics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are the essential first step for laboratory detection of influenza virus infections. Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).

According to APO Research, the global Influenza Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Influenza Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Influenza Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Influenza Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Influenza Diagnostics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Influenza Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Influenza Diagnostics Market by Company

BD

Abbott (Include Alere)

Roche

SIEMENS

Analytik Jena

Quidel

Thermo Fisher

Meridian Bioscience

BioMerieux

Sekisui Diagnostics

Response Biomedical

SA Scientific

Influenza Diagnostics Segment by Type

RIDT

RT-PCR

Cell Culture

Others

Influenza Diagnostics Segment by Application

Hospitals

POCT

Others

Influenza Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Influenza Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Influenza Diagnostics Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Influenza Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Influenza Diagnostics Market Share by Region (2021-2026) Table 4. Global Influenza Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Influenza Diagnostics Market Share by Region (2027-2032) Table 6. Global Influenza Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Influenza Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Influenza Diagnostics Market Size Share by Type (2021-2026) Table 9. Global Influenza Diagnostics Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Influenza Diagnostics Market Size Share Forecasted by Type (2027-2032) Table 11. North America Influenza Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Influenza Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Influenza Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Influenza Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Influenza Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Influenza Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Influenza Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Influenza Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Influenza Diagnostics Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Influenza Diagnostics Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Influenza Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Influenza Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Influenza Diagnostics Market Size Share by Application (2021-2026) Table 24. Global Influenza Diagnostics Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Influenza Diagnostics Market Size Share Forecasted by Application (2027-2032) Table 26. North America Influenza Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Influenza Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Influenza Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Influenza Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Influenza Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Influenza Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Influenza Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Influenza Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Influenza Diagnostics Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Influenza Diagnostics Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Influenza Diagnostics Industry Trends Table 37. Influenza Diagnostics Industry Drivers Table 38. Influenza Diagnostics Industry Opportunities and Challenges Table 39. Influenza Diagnostics Industry Restraints Table 40. Global Influenza Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Influenza Diagnostics Revenue Market Share by Company (2021-2026) Table 42. Global Influenza Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Influenza Diagnostics Key Company Headquarters & Area Served Table 44. Global Influenza Diagnostics Company, Product Type & Application Table 45. Global Influenza Diagnostics Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. BD Company Information Table 49. BD Business Overview Table 50. BD Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. BD Influenza Diagnostics Product Portfolio Table 52. BD Recent Development Table 53. Abbott (Include Alere) Company Information Table 54. Abbott (Include Alere) Business Overview Table 55. Abbott (Include Alere) Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Abbott (Include Alere) Influenza Diagnostics Product Portfolio Table 57. Abbott (Include Alere) Recent Development Table 58. Roche Company Information Table 59. Roche Business Overview Table 60. Roche Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Roche Influenza Diagnostics Product Portfolio Table 62. Roche Recent Development Table 63. SIEMENS Company Information Table 64. SIEMENS Business Overview Table 65. SIEMENS Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. SIEMENS Influenza Diagnostics Product Portfolio Table 67. SIEMENS Recent Development Table 68. Analytik Jena Company Information Table 69. Analytik Jena Business Overview Table 70. Analytik Jena Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Analytik Jena Influenza Diagnostics Product Portfolio Table 72. Analytik Jena Recent Development Table 73. Quidel Company Information Table 74. Quidel Business Overview Table 75. Quidel Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Quidel Influenza Diagnostics Product Portfolio Table 77. Quidel Recent Development Table 78. Thermo Fisher Company Information Table 79. Thermo Fisher Business Overview Table 80. Thermo Fisher Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Thermo Fisher Influenza Diagnostics Product Portfolio Table 82. Thermo Fisher Recent Development Table 83. Meridian Bioscience Company Information Table 84. Meridian Bioscience Business Overview Table 85. Meridian Bioscience Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Meridian Bioscience Influenza Diagnostics Product Portfolio Table 87. Meridian Bioscience Recent Development Table 88. BioMerieux Company Information Table 89. BioMerieux Business Overview Table 90. BioMerieux Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. BioMerieux Influenza Diagnostics Product Portfolio Table 92. BioMerieux Recent Development Table 93. Sekisui Diagnostics Company Information Table 94. Sekisui Diagnostics Business Overview Table 95. Sekisui Diagnostics Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sekisui Diagnostics Influenza Diagnostics Product Portfolio Table 97. Sekisui Diagnostics Recent Development Table 98. Response Biomedical Company Information Table 99. Response Biomedical Business Overview Table 100. Response Biomedical Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Response Biomedical Influenza Diagnostics Product Portfolio Table 102. Response Biomedical Recent Development Table 103. SA Scientific Company Information Table 104. SA Scientific Business Overview Table 105. SA Scientific Influenza Diagnostics Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. SA Scientific Influenza Diagnostics Product Portfolio Table 107. SA Scientific Recent Development Table 108. North America Influenza Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Influenza Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Influenza Diagnostics Market Share by Country (2021-2026) Table 111. North America Influenza Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Influenza Diagnostics Market Share Forecast by Country (2027-2032) Table 113. Europe Influenza Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Influenza Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Influenza Diagnostics Market Share by Country (2021-2026) Table 116. Europe Influenza Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Influenza Diagnostics Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Influenza Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Influenza Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 120. Asia-Pacific Influenza Diagnostics Market Share by Country (2021-2026) Table 121. Asia-Pacific Influenza Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Asia-Pacific Influenza Diagnostics Market Share Forecast by Country (2027-2032) Table 123. Latin America Influenza Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Latin America Influenza Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 125. Latin America Influenza Diagnostics Market Share by Country (2021-2026) Table 126. Latin America Influenza Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Latin America Influenza Diagnostics Market Share Forecast by Country (2027-2032) Table 128. Middle East & Africa Influenza Diagnostics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Middle East & Africa Influenza Diagnostics Market Size by Country (2021-2026) & (US$ Million) Table 130. Middle East & Africa Influenza Diagnostics Market Share by Country (2021-2026) Table 131. Middle East & Africa Influenza Diagnostics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Middle East & Africa Influenza Diagnostics Market Share Forecast by Country (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Influenza Diagnostics Product Image Figure 3. Global Influenza Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Influenza Diagnostics Market Size (2021-2032) & (US$ Million) Figure 5. Global Influenza Diagnostics Market Share by Region: 2025 VS 2032 Figure 6. Global Influenza Diagnostics Market Share by Region (2021-2032) Figure 7. North America Influenza Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Influenza Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Influenza Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Influenza Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Influenza Diagnostics Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. RIDT Image Figure 13. Global RIDT Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. RT-PCR Image Figure 15. Global RT-PCR Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Cell Culture Image Figure 17. Global Cell Culture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Influenza Diagnostics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Influenza Diagnostics Market Share by Type 2025 VS 2032 Figure 22. North America Influenza Diagnostics Market Size Share by Type (2021-2032) Figure 23. Europe Influenza Diagnostics Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Influenza Diagnostics Market Size Share by Type (2021-2032) Figure 25. Latin America Influenza Diagnostics Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Influenza Diagnostics Market Size Share by Type (2021-2032) Figure 27. Hospitals Image Figure 28. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. POCT Image Figure 30. Global POCT Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Others Image Figure 32. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Influenza Diagnostics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Influenza Diagnostics Market Share by Application 2025 VS 2032 Figure 35. North America Influenza Diagnostics Market Size Share by Application (2021-2032) Figure 36. Europe Influenza Diagnostics Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Influenza Diagnostics Market Size Share by Application (2021-2032) Figure 38. Latin America Influenza Diagnostics Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Influenza Diagnostics Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Influenza Diagnostics Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Influenza Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Influenza Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Influenza Diagnostics Market Share by Country (2021-2032) Figure 45. Europe Influenza Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Influenza Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Influenza Diagnostics Market Share by Country (2021-2032) Figure 48. Asia-Pacific Influenza Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Influenza Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Influenza Diagnostics Market Share by Country (2021-2032) Figure 51. Latin America Influenza Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Influenza Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Influenza Diagnostics Market Share by Country (2021-2032) Figure 54. Middle East & Africa Influenza Diagnostics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Influenza Diagnostics Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Influenza Diagnostics Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • RIDT
  • RT-PCR
  • Cell Culture
  • Others
Applications
  • Hospitals
  • POCT
  • Others
Companies covered
  • BD
  • Abbott (Include Alere)
  • Roche
  • SIEMENS
  • Analytik Jena
  • Quidel
  • Thermo Fisher
  • Meridian Bioscience
  • BioMerieux
  • Sekisui Diagnostics
  • Response Biomedical
  • SA Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Influenza Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Influenza Diagnostics Market Size by Region (2021-2032)
  5. 1.4.1 Global Influenza Diagnostics Market Size by Region (2021-2026)
  6. 1.4.2 Global Influenza Diagnostics Market Size by Region (2027-2032)
  7. 1.5 Key Regions Influenza Diagnostics Market Size (2021-2032)
  8. 1.5.1 North America Influenza Diagnostics Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Influenza Diagnostics Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Influenza Diagnostics Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Influenza Diagnostics Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Influenza Diagnostics Market Size Growth Rate (2021-2032)
2 Influenza Diagnostics Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 RIDT
  3. 2.1.2 RT-PCR
  4. 2.1.3 Cell Culture
  5. 2.1.4 Others
  6. 2.2 Global Influenza Diagnostics Market Size by Type
  7. 2.2.1 Global Influenza Diagnostics Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Influenza Diagnostics Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Influenza Diagnostics Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Influenza Diagnostics Market Size by Regions
  11. 2.3.1 North America Influenza Diagnostics Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Influenza Diagnostics Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Influenza Diagnostics Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Influenza Diagnostics Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Influenza Diagnostics Market Size Breakdown by Type (2021-2026)
3 Influenza Diagnostics Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 POCT
  4. 3.1.3 Others
  5. 3.2 Global Influenza Diagnostics Market Size by Application
  6. 3.2.1 Global Influenza Diagnostics Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Influenza Diagnostics Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Influenza Diagnostics Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Influenza Diagnostics Market Size by Regions
  10. 3.3.1 North America Influenza Diagnostics Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Influenza Diagnostics Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Influenza Diagnostics Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Influenza Diagnostics Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Influenza Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Influenza Diagnostics Industry Trends
  2. 4.2 Influenza Diagnostics Industry Drivers
  3. 4.3 Influenza Diagnostics Industry Opportunities and Challenges
  4. 4.4 Influenza Diagnostics Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Influenza Diagnostics Revenue (2021-2026)
  2. 5.2 Global Influenza Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Influenza Diagnostics Key Company Headquarters & Area Served
  4. 5.4 Global Influenza Diagnostics Company, Product Type & Application
  5. 5.5 Global Influenza Diagnostics Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Influenza Diagnostics Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Influenza Diagnostics Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Influenza Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 BD
  2. 6.1.1 BD Company Information
  3. 6.1.2 BD Business Overview
  4. 6.1.3 BD Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 BD Influenza Diagnostics Product Portfolio
  6. 6.1.5 BD Recent Developments
  7. 6.2 Abbott (Include Alere)
  8. 6.2.1 Abbott (Include Alere) Company Information
  9. 6.2.2 Abbott (Include Alere) Business Overview
  10. 6.2.3 Abbott (Include Alere) Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Abbott (Include Alere) Influenza Diagnostics Product Portfolio
  12. 6.2.5 Abbott (Include Alere) Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Roche Influenza Diagnostics Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 SIEMENS
  20. 6.4.1 SIEMENS Company Information
  21. 6.4.2 SIEMENS Business Overview
  22. 6.4.3 SIEMENS Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 SIEMENS Influenza Diagnostics Product Portfolio
  24. 6.4.5 SIEMENS Recent Developments
  25. 6.5 Analytik Jena
  26. 6.5.1 Analytik Jena Company Information
  27. 6.5.2 Analytik Jena Business Overview
  28. 6.5.3 Analytik Jena Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Analytik Jena Influenza Diagnostics Product Portfolio
  30. 6.5.5 Analytik Jena Recent Developments
  31. 6.6 Quidel
  32. 6.6.1 Quidel Company Information
  33. 6.6.2 Quidel Business Overview
  34. 6.6.3 Quidel Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Quidel Influenza Diagnostics Product Portfolio
  36. 6.6.5 Quidel Recent Developments
  37. 6.7 Thermo Fisher
  38. 6.7.1 Thermo Fisher Company Information
  39. 6.7.2 Thermo Fisher Business Overview
  40. 6.7.3 Thermo Fisher Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Thermo Fisher Influenza Diagnostics Product Portfolio
  42. 6.7.5 Thermo Fisher Recent Developments
  43. 6.8 Meridian Bioscience
  44. 6.8.1 Meridian Bioscience Company Information
  45. 6.8.2 Meridian Bioscience Business Overview
  46. 6.8.3 Meridian Bioscience Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Meridian Bioscience Influenza Diagnostics Product Portfolio
  48. 6.8.5 Meridian Bioscience Recent Developments
  49. 6.9 BioMerieux
  50. 6.9.1 BioMerieux Company Information
  51. 6.9.2 BioMerieux Business Overview
  52. 6.9.3 BioMerieux Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 BioMerieux Influenza Diagnostics Product Portfolio
  54. 6.9.5 BioMerieux Recent Developments
  55. 6.10 Sekisui Diagnostics
  56. 6.10.1 Sekisui Diagnostics Company Information
  57. 6.10.2 Sekisui Diagnostics Business Overview
  58. 6.10.3 Sekisui Diagnostics Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sekisui Diagnostics Influenza Diagnostics Product Portfolio
  60. 6.10.5 Sekisui Diagnostics Recent Developments
  61. 6.11 Response Biomedical
  62. 6.11.1 Response Biomedical Company Information
  63. 6.11.2 Response Biomedical Business Overview
  64. 6.11.3 Response Biomedical Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Response Biomedical Influenza Diagnostics Product Portfolio
  66. 6.11.5 Response Biomedical Recent Developments
  67. 6.12 SA Scientific
  68. 6.12.1 SA Scientific Company Information
  69. 6.12.2 SA Scientific Business Overview
  70. 6.12.3 SA Scientific Influenza Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 SA Scientific Influenza Diagnostics Product Portfolio
  72. 6.12.5 SA Scientific Recent Developments
7 North America
  1. 7.1 North America Influenza Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Influenza Diagnostics Market Size by Country (2021-2026)
  3. 7.3 North America Influenza Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Influenza Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Influenza Diagnostics Market Size by Country (2021-2026)
  3. 8.3 Europe Influenza Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Influenza Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Influenza Diagnostics Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Influenza Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Influenza Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Influenza Diagnostics Market Size by Country (2021-2026)
  3. 10.3 South America Influenza Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Influenza Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Influenza Diagnostics Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Influenza Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst